Product Information
RUFINAMIDE 200 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $0.8810 per EA under NDC 42571039112. Its NADAC has been published 138 times since Feb 14, 2024.
FDA first approved this application on May 15, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Micro Labs LimitedNDC
42571039112
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
RUFINAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216688FDA Approved
5/15/2023
TE Code
AB
On Market Since
7/1/2023
Price Statistics
The NADAC for RUFINAMIDE 200 MG TABLET has been published 138 times since Feb 14, 2024, and over the history we have for it it has declined 55.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8810 per EA |
|---|---|
| All-time high | $1.9811 (Apr 10, 2024) |
| All-time low | $0.8320 (Aug 19, 2026) |
| 52-week high | $1.4400 |
| 52-week low | $0.8320 |
| Median price | $1.4481 |
| Average price | $1.3626 |
| Largest weekly change | -14.2% (Nov 19, 2025) |
| Weeks tracked | 138 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the RUFINAMIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
RUFINAMIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RUFINAMIDE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RUFINAMIDE 200 MG TABLET, manufactured by Micro Labs Limited, is $0.8810 per EA (NDC 42571039112), effective Sep 30, 2026.
How has the price of RUFINAMIDE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for RUFINAMIDE 200 MG TABLET has declined 55.5%. It has been tracked across 138 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for RUFINAMIDE 200 MG TABLET?
Since Feb 14, 2024, the NADAC for RUFINAMIDE 200 MG TABLET has ranged from a low of $0.8320 (Aug 19, 2026) to a high of $1.9811 (Apr 10, 2024), with a median of $1.4481 per EA.
Are there cheaper alternatives to RUFINAMIDE 200 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of RUFINAMIDE 200 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RUFINAMIDE 200 MG TABLET?
RUFINAMIDE 200 MG TABLET (NDC 42571039112) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.